Indicators
Indicators
Value
Direction
MACD(12,26,9)
0.010
Neutral
RSI(14)
44.704
Neutral
STOCH(KDJ)(9,3,3)
18.423
Sell
ATR(14)
0.068
Low Volatility
CCI(14)
-56.791
Neutral
Williams %R
75.685
Sell
TRIX(12,20)
0.254
Sell
StochRSI(14)
0.000
Oversold
Search
Evogene Ltd
EVGNAdd to Watchlist
0.492USD
-0.028-5.46%
Close 07-28 16:00（ET）Quotes delayed by 15 min
5.12MMarket Cap
LossP/E TTM
View Detailed Chart
TradingKey ChartIntraday
1m
30m
1h
D
W
M
D
Today
-5.46%
5 Days
-7.61%
1 Month
+26.41%
6 Months
-53.62%
Year to Date
-55.31%
1 Year
-61.59%
Key Figures
0.539Open
0.539High
77.31KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.74%Turnover Ratio
0.520Prev. Close
0.490Low
26.17KTurnover
LossP/E Static
8.48P/B
0.00%Div Yield TTM
-45.06%ROA
2.42052wk High
0.55Volume Ratio
-16.48MNet Profit
10.41MShares
-1.0776EPS TTM
1.36Beta
-482.60%ROE
0.66052wk Low
9.46%Amplitude
61.08%Gross Margin
5.12MMarket Cap
5.06Reward/Risk
4.06%Risk Rate
TradingKey Stock Score of Evogene Ltd
Currency: USD Updated: 2026-07-28Key Insights
Evogene Ltd's fundamentals are relatively healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 125 out of 385 in the Biotechnology & Medical Research industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 2.15.In the medium term, the stock price is expected to trend down.Despite a good stock market performance and outperforming fundamentals over the past month, the technicals don't support the current trend.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Evogene Ltd's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Neutral
Evogene Ltd Highlights
StrengthsRisks
Evogene Ltd is an Israel-based company, engaged in leveraging computational biology to design products for life-science-based industries including human health, agriculture, and industrial applications. Leveraging Big Data and Artificial Intelligence while incorporating a deep understanding of biology, Evogene established its technology, the Computational Predictive Biology (CPB) platform, to computationally design microbes, small molecules and genes as the core components for life-science products. Evogene holds a number of subsidiaries utilizing the CPB platform, for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits and ag-solutions for castor oil production.
Growing
The company is in a growing phase, with the latest annual income totaling USD 3.85M.
Fairly Valued
The company’s latest PE is -0.46, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 201.08K shares, decreasing 77.10% quarter-over-quarter.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of 1.66.
Analyst Rating
Based on
1
analysts
Buy
Current Rating
2.150
Target Price
+296.31%
Upside Space
Evogene Ltd News
More news coming soon, stay tuned...
Earnings Forecast
Analyst Rating
Based on
1
analysts
Buy
Current Rating
2.150
Target Price
+296.31%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
496
Total
6
Median
7
Average
Company name
Ratings
Analysts
Evogene Ltd
EVGN
1
Beigene Ltd
ONC
28
argenx SE
ARGX
26
Ionis Pharmaceuticals Inc
IONS
26
IQVIA Holdings Inc
IQV
25
Insmed Inc
INSM
23
1
2
3
...
99
Indicators
Moving Average
Indicators
Value
Direction
MA5
0.529
Sell
MA10
0.552
Sell
MA20
0.503
Sell
MA50
0.562
Sell
MA100
0.680
Sell
MA200
0.887
Sell
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Evogene Ltd Info
Evogene Ltd is an Israel-based company, engaged in leveraging computational biology to design products for life-science-based industries including human health, agriculture, and industrial applications. Leveraging Big Data and Artificial Intelligence while incorporating a deep understanding of biology, Evogene established its technology, the Computational Predictive Biology (CPB) platform, to computationally design microbes, small molecules and genes as the core components for life-science products. Evogene holds a number of subsidiaries utilizing the CPB platform, for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits and ag-solutions for castor oil production.
Ticker SymbolEVGN
CompanyEvogene Ltd
CEOEmber (Brian)
Websitehttps://evogene.com/
Shareholders
Related Instruments
+1.98%
+0.31%
+1.71%
+2.50%
+0.83%
+2.37%
+4.42%
+2.57%
+2.92%
+2.37%
+1.72%
+2.35%
+3.47%
+3.33%
+4.61%
0.00%
+4.24%
+0.60%
+1.34%
-1.93%Popular Instruments
FAQs
What is the current price of Evogene Ltd (EVGN)?
The current price of Evogene Ltd (EVGN) is 0.49.
What is the symbol of Evogene Ltd?
The ticker symbol of Evogene Ltd is EVGN.
What is the 52-week high of Evogene Ltd?
The 52-week high of Evogene Ltd is 2.42.
What is the 52-week low of Evogene Ltd?
The 52-week low of Evogene Ltd is 0.66.
What is the market capitalization of Evogene Ltd?
The market capitalization of Evogene Ltd is 5.12M.
Is Evogene Ltd (EVGN) currently rated as Buy, Hold, or Sell?
According to analysts, Evogene Ltd (EVGN) has an overall rating of Buy, with a price target of 2.15.
What is the Earnings Per Share (EPS TTM) of Evogene Ltd (EVGN)?
The Earnings Per Share (EPS TTM) of Evogene Ltd (EVGN) is -1.08.